Millions of American families rely on FSAs, HSAs, and other tax-preferred accounts to help meet their basic healthcare needs, including the purchase of OTC medicines.
CHPA applauds New Hampshire for becoming the 35th state to adopt the real-time, stop-sale technology called the National Precursor Log Exchange (NPLEx), a system used by retailers across the country to help prevent the illegal sale of pseudoephedrine.
Restricting consumers’ ability to utilize their own FSAs and HSAs and other tax-preferred accounts impose an unfair cost increase on individuals and families at a time when many are struggling financially.
CHPA applauds the U.S. House Ways and Means Health Subcommittee for today’s hearing, examining the benefits of consumer access to tax-preferred savings accounts, HSAs and FSAs.
The CHPA Educational Foundation today released findings from a study examining the common attitudes and behaviors of parents when administering pediatric over-the-counter (OTC) liquid medicines to young children.
Colorado Governor John Hickenlooper signed into law HB 1307, legislation prohibiting the sale of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM) to minors.
CHPA applauds FDA for issuing a recent order in support of the full and complete switch from prescription to nonprescription status for the laxative active ingredient polyethylene glycol (PEG) 3350.
CHPA thanks Governor Walker for signing this important bill into law as well as Senator Stroebel and Representative Kremer for their leadership and commitment to passing legislation aimed at addressing the issue of teen OTC cough medicine abuse
